Brief: Vitrolife Q1 EBITDA Up At SEK 163 Million
April 22 (Reuters) - Vitrolife AB VITR.ST :
* INTERIM REPORT JANUARY-MARCH 2021: RECOVERY AND GOOD
PROFITABILITY
* Q1 SALES AMOUNTED TO SEK 379 (334) MILLION, CORRESPONDING
TO AN
INCREASE OF 14 PERCENT IN SEK.
* Q1 OPERATING INCOME BEFORE DEPRECIATION AND AMORTISATION
(EBITDA) AMOUNTED TO SEK 163 (116) MILLION
Source text for Eikon: ID:nWkr2DpqV8
Further company coverage: VITR.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587696600;))